What just happened?

Quote




anonymous said:
My job is safe & I have ZERO excitement now for launching this obesity drug.

Im sure to get paid my whole district will have to hit goal anyway.

FUCK Lilly
Click to expand...


Yeah F* Lilly! But can I ask what made you so confident about keeping your gig? My understanding is no one knows until Tuesday. They need to fill 363 positions (370 two months ago) but have at least 400 reps (sr. Care + PC3). So, please tell us if you have any insight on how they made the decision to keep Vs layoff. Is it tenure, performance, who you know in HQ, qualifications, recommendation from DSM?

op
 




anonymous said:
No

Somehow leadership said they didn’t frisée that senior care was worthless with them selling Trulicity to nursing homes lmaooo. So they decided to eliminate senior care all of the sudden.
Then they decided that to be fair to all 44 senior care reps, that they’d let them compete for the obesity positions that were already awarded to PC3 about 2 months ago.

So now with their wisdom & fancy maneuvering, they’ve pushed off 370 PC3 reps right before they launch obesity.

Genius move it tell ya. Fucking genius.

Oh yeah, they last minute decided that there’d be less obesity territories than originally promised just 2 months ago.
Our leadership is top notch and forward thinkers lolololol lmaooo lolololol
Click to expand...
 




Since launch, it’s been obvious that too many people have too little knowledge and experience in the industry especially post Covid. Trying to discuss with leadership what was really happening in the marketplace prior to launch was met with complete disregard and statements such as “your just making excuses”. It seems like management, not sure which level because there are MANY HIGH PAID CHIEFS are MANAGING BY THE SEAT OF THEIR PANTS! Everyday I’m left speechless by the lack of preparedness and keep asking myself WHAT THE FUCK IS HAPPENING AND WHO IS RESPONSIBLE FOR THIS SHIT SHOW!
 




anonymous said:
My job is safe & I have ZERO excitement now for launching this obesity drug.

Im sure to get paid my whole district will have to hit goal anyway.

FUCK Lilly
Click to expand...
Tell me without telling me you’re young and dumb. This is pharmaceuticals it’s not for the faint of heart. Lilly ran the numbers through an advanced MBA model. Best part after January 1st and after Monjaro launches in October they will hire thirsty reps for half the price. Lilly will enjoy the tax write offs and claim to be doing gods work.
 








Why is Lilly marketing and recruiting for the obesity positions on the major job boards? If you think there are only 400 people being considered for these openings, you are not counting the thousands of external applicants lining up.

---------------

LDO Obesity Specialty Territory Manager

Key Responsibilities
The LDO Obesity Specialty Territory Managers will be responsible for developing relationships with practitioners who are prescribers/influencers of treatment for the disease states represented in the Lilly Obesity portfolios. These territory managers will be responsible for account-based selling in dedicated obesity practices and non-dedicated obesity practices to determine how to help more patients get the benefits of an obesity treatment. The Specialty representative will build relationships with these key customers to increase Lilly’s ability to drive adoption of our new and existing therapies. Identify and develop business relationships with key customers, state and local advocacy groups, teaching institutions, key influencers/prescribers, and managed care organizations and establish oneself as a true expert and resource.
  • Develop deep professional/industry knowledge in multiple disease states represented in Lilly Diabetes and Obseity and Endocrine portfolios including knowledge of competitive products.
  • Identify and develop business relationships with key customers, state and local advocacy groups, teaching institutions, key influencers/prescribers, and managed care organizations and establish oneself as a true expert and resource.
  • Drive sales growth of the product portfolio.
  • Build outstanding customer experiences by engaging in active dialogue to understand the customer’s needs and delivering appropriate resources and relevant information to influence appropriate use of product portfolio.
  • Effective selling of multiple products on a single call.
  • Effective account management skills to develop an account/customer target list, evaluate and set an appropriate territory workload, and achieve key efficiency parameters.
  • Sell in a changing health care environment, utilizing critical thinking and strategic mindset to understand the environment (payer, health systems, business) and gain access to the customers to make an impact on patients’ lives.
  • Work colabortativily with territory and Lilly partners to leverage impact across your territory and district.
  • Operate with high integrity and comply with Lilly policies and procedures.



Basic Qualifications
  • Bachelor’s degree as well as Professional certification or license required to perform this position (if required by a specific state)
  • Valid driver’s license and acceptable driving record
  • Qualified candidates must be legally authorized to be employed in the United States. Lilly does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status) for this employment position.


Additional Skills/Preferences
  • 2 or more years of sales experience (pharmaceutical or non-pharmaceutical) following the completion of undergraduate degree.
  • 1-3 or more years of work experience following the completion of undergraduate degree, OR Graduate degree – Masters, MBA, PharmD
  • Bilingual skills as aligned with territory and customer needs
  • Live within the territory or within 30 miles of territory boundaries
  • Excellent interpersonal skills with ability to coordinate with partners
  • Excellent communication and organizational skills
  • Ability to collaborate in a team environment
  • Ability to build and maintain lasting relationships with key accounts and caregivers
  • Demonstrated ability to learn, apply and communicate technical/scientific knowledge
  • Proven leadership and teamwork with peers; ability to influence teammates to build a strong performance-centered culture
  • Top 1/3 portfolio sales results, 1 out of last 3 years
  • Demonstrated business acumen and business ownership mentality
  • Account Based Selling experience
  • Demonstrated project management, problem solving and analytical skills


Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at Lilly, please email Lilly Human Resources ( Lilly_Recruiting_Compliance@lists.lilly.com ) for further assistance. Please note This email address is intended for use only to request an accommodation as part of the application process. Any other correspondence will not receive a response.
 












I don’t get it. Lilly is posting openings nationwide for obesity but they recently let some of the sales force that was supposed to sell this indication go? Why? What exactly happened?
 












anonymous said:
You’re the idiot if you think it takes that many of you to sell this drug. Cuts coming to pc1 and 2 next. Or does it take two of you to say the same thing? Haha . Waste of money.
The DBU is the worst place to be. Why DO you all stay there?
Click to expand...



it’s okay. I get it you were let go. Business is business and that’s okay. Sharpen your selling skills and don’t let this make you so upset. Reminder, nothing sells itself!
 




The history of Lilly layoffs started in 2006. Prior to that the company was honorable and ethical. It was post 2006 when the games started. 18 years later they are still playing games.
 




anonymous said:
it’s okay. I get it you were let go. Business is business and that’s okay. Sharpen your selling skills and don’t let this make you so upset. Reminder, nothing sells itself!
Click to expand...

I’ve never been in the DBU nor would I go there. All of this is why. It’s going to keep happening. If you think all of the pc1 and 2 are needed, you’re crazy. It doesn’t take a rocket scientist to see it. I think YOU better sharpen your selling skills if you want to ever get out of a primary care job. Typical response from a “veteran” in primary care that drops samples and feeds staff. Haha. When you finally get into a real specialty role where dialogue matters, let us know!
 




anonymous said:
Yeah F* Lilly! But can I ask what made you so confident about keeping your gig? My understanding is no one knows until Tuesday. They need to fill 363 positions (370 two months ago) but have at least 400 reps (sr. Care + PC3). So, please tell us if you have any insight on how they made the decision to keep Vs layoff. Is it tenure, performance, who you know in HQ, qualifications, recommendation from DSM?

op
Click to expand...
Certain parts of the country that have bad access will be eliminated. States like Wisconsin, Minnesota, Washington, Vermont, North Dakota, South Dakota etc..
 








anonymous said:
I don’t get it. Lilly is posting openings nationwide for obesity but they recently let some of the sales force that was supposed to sell this indication go? Why? What exactly happened?
Click to expand...

Because lilly figured out pc3 is the most incompetent buncha goobers to ever sling pills.

Y'all shoulda seen the writing on the wall when they hired an entire contract sales force to sell your drug right under your nose. Pc3 completely fumbled emgality, almost fumbled jardiance and yall thought you would get rewarded with a shinny new specialty title and another drug to ruin. Gimme a break. Lilly won't stop til all y'all are gone.
 




anonymous said:
Because lilly figured out pc3 is the most incompetent buncha goobers to ever sling pills.

Y'all shoulda seen the writing on the wall when they hired an entire contract sales force to sell your drug right under your nose. Pc3 completely fumbled emgality, almost fumbled jardiance and yall thought you would get rewarded with a shinny new specialty title and another drug to ruin. Gimme a break. Lilly won't stop til all y'all are gone.
Click to expand...

Hmmmm…Where to begin?…I guess I’ll begin with this -You are clearly bitter & resentful, and you are also ignorant, full of “shiitake”, and really just plain stupid…
We “fumbled Emgality”?…How exactly is PC3 to blame for Emgality?..The entire CGRP marketplace -Emgality, Aimovig, Anjovy- has underperformed due in large part to Nurtec; that’s why all 3 injectable CGRPs will soon no longer have any sales force representation! So, the SPEC reps aren’t to blame for the lack of success? Not to mention the extraordinary blunder Lilly made with the Emgality vs Nurtec head2head study, but PC3 is to blame, right?
It was made very clear to PC3 from the beginning that Emgality was not that important, and that point was further illustrated by with Jardiance weighted more than double against Emgality (70/30).
Oh, and speaking of Jardiance, I’ll just repeat this little stat for you -Jardiance revenue grew by 54% in Q2; despite the fact the entire SGLT2 marketplace is in decline & rapidly losing ground to GLP-1s, and our very own behemoth, Mounjaro.
Now that I’ve spanked your pathetic little ass, feel free to go back under the giant rock you live, curl up in the fetal position, and cry yourself to sleep.
 








Top Bottom
Back
Quote